A few weeks after starting my micro-dose program, I realized I needed a plan for protein and gut support, Gina Vaynshteyn, VP of Commerce at SHE Media says
Retatrutides Phase 2 trial data showed 24.2% average weight loss at the 12 mg dose over 48 weeks
57% of EU liver specialists surveyed by Ipsos in Q1 25 (prior to approval in August) expected diagnoses to rise with an approved GLP1
Enhanced Fat Distribution: Beyond reducing overall body mass, it may improve fat distribution by targeting visceral fat, which is closely associated with higher risks of health complications
This may include writing a prescription if they feel its necessary
This primarily appears to be due to clinical results since GLP-1s lower A1C, reduce weight, improve cardiovascular outcomes, and potentially many other benefits